- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.92 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 20 x ACT: ACETATE ION(Non-functional Binders)
- 27 x SO4: SULFATE ION(Non-functional Binders)
SO4.12: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.13: 2 residues within 4Å:- Chain A: R.44, S.45
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.15: 1 residues within 4Å:- Chain A: K.473
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain A: Y.11, W.348, E.349, Q.350, R.353
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain A: E.254, R.257
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain A: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.19: 2 residues within 4Å:- Chain A: H.290, K.293
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain A: E.111, R.170, P.428
Ligand excluded by PLIPSO4.21: 2 residues within 4Å:- Chain A: S.464, S.465
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain A: Q.226, T.272, H.273, V.276
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain A: R.277, V.305, H.306
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain A: F.331, P.332, N.333, T.334
Ligand excluded by PLIPSO4.25: 7 residues within 4Å:- Chain A: D.453, G.454, S.455, W.494, H.495, R.496, Q.497
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain A: T.187, K.198, G.199
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain A: R.285, P.319, A.320, T.369
Ligand excluded by PLIPSO4.40: 6 residues within 4Å:- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.41: 2 residues within 4Å:- Chain B: R.44, S.45
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain B: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.43: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.44: 3 residues within 4Å:- Chain B: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain B: I.158, P.159, H.162
Ligand excluded by PLIPSO4.46: 2 residues within 4Å:- Chain B: K.321, R.329
Ligand excluded by PLIPSO4.47: 3 residues within 4Å:- Chain B: R.277, V.305, H.306
Ligand excluded by PLIPSO4.48: 5 residues within 4Å:- Chain B: Q.226, T.272, H.273, N.275, V.276
Ligand excluded by PLIPSO4.49: 1 residues within 4Å:- Chain B: R.262
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain B: S.45, R.47
Ligand excluded by PLIP- 2 x HKW: 6-[3,3-dimethyl-2-[(1~{E},3~{E},5~{E})-5-(1,3,3-trimethylindol-2-ylidene)penta-1,3-dienyl]indol-1-ium-1-yl]-~{N}-[[1-[[(1~{S},2~{R},3~{R},4~{S},6~{S})-2,3,4,6-tetrakis(oxidanyl)cyclohexyl]methyl]-1,2,3-triazol-4-yl]methyl]hexanamide(Covalent)
HKW.28: 25 residues within 4Å:- Chain A: D.127, F.128, W.179, N.234, E.235, L.241, S.242, G.243, Y.244, P.245, F.246, Y.313, E.340, W.381, F.397, V.398
- Chain B: L.314, D.315, L.317, E.349, D.358, M.361, Q.362, H.365, R.463
15 PLIP interactions:10 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:L.241, A:Y.244, A:P.245, A:E.340, B:D.358, B:M.361, B:Q.362, B:H.365, B:R.463
- Hydrogen bonds: A:D.127, A:W.179, A:N.234, A:E.235, A:E.235
- Water bridges: A:E.235
HKW.51: 11 residues within 4Å:- Chain B: D.127, F.128, W.179, N.234, E.235, F.246, Y.313, E.340, C.342, W.381, N.396
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:E.340
- Hydrogen bonds: B:D.127, B:W.179, B:N.234, B:E.235, B:E.235, B:N.396
- Water bridges: B:E.235
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Artola, M. et al., Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish. J.Am.Chem.Soc. (2019)
- Release Date
- 2019-03-27
- Peptides
- Glucosylceramidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
SMTL ID : 6q6k.1
Crystal structure of recombinant human beta-glucocerebrosidase in complex with cyclophellitol activity based probe with Cy5 tag (ME569)
Glucosylceramidase
Related Entries With Identical Sequence
1ogs.1 | 1ogs.2 | 1y7v.1 | 1y7v.2 | 1y7v.3 | 1y7v.4 | 1y7v.5 | 1y7v.6 | 2f61.1 | 2f61.2 | 2j25.1 | 2j25.2 | 2nsx.1 | 2nsx.2 | 2nsx.3 | 2nsx.4 | 2nsx.5 | 2nsx.6 | 2nsx.7 | 2nsx.8 | 2nsx.9 | 2nt0.1 | 2nt0.2 | 2nt0.3 | 2nt0.4 | 2nt1.1 | 2nt1.2 | 2nt1.3 | 2nt1.4 | 2nt1.5 more...less...3gxd.1 | 3gxf.1 | 3gxf.2 | 3gxi.1 | 3gxi.2 | 3gxi.3 | 3gxi.4 | 3gxm.1 | 3gxm.2 | 3gxm.3 | 3gxm.4 | 3rik.1 | 3rik.2 | 3ril.1 | 3ril.2 | 6moz.1 | 6moz.2 | 6q1n.1 | 6q1n.2 | 6q1p.1 | 6q1p.2 | 6q1p.3 | 6q6l.1 | 6q6n.1 | 6tjj.1 | 6tjj.2 | 6ytp.1 | 6ytp.2 | 6yut.1 | 6yut.2 | 6yv3.1 | 6yv3.2 | 6z39.1 | 8p3e.1 | 8p41.1 | 8p41.2